Each entry maps to the recognition-ladder rung its change occurred at.
Rung 5Guideline actionGuideline committees revise recommendations, grades, or positioning.
Rung 6Regulatory actionAuthorities update labels, indications, or approval status.
Rung 7Payer/coverage actionPayers change access, restrictions, or formulary placement.
Recorded changes
Dated, sourced evidence changes
Entries are recorded after they occur, newest first, each with a source link and a date.
Rung 5 — Guideline action
NCCN adds free weekly guideline-change updates
NCCN introduced a free Guidelines Weekly Updates email alongside a paid Flash Updates tier, publishing what changed across its guideline library on a fixed cadence.
A public guideline-change delivery pattern now exists; it documents the change flow modeled as rung 5 transitions.
FDA finalizes guidance on communicating scientific information about unapproved uses
FDA published its final guidance describing how firms may communicate truthful, non-misleading scientific information about unapproved uses, including requirements to keep sources unaltered, complete, and conflict-disclosed.
Sets the source-integrity standard that public evidence records are designed to meet.
ICER publishes annual Launch Price and Access Report
ICER released its annual review of launch prices and access conditions — an independent, conflict-disclosed assessment of how new products enter coverage.
Independent assessments of access conditions are the reference standard for coverage-change records.